
Back in the bloodstream
Abbott is dusting off its 'We Give Blood' campaign and rolling it back out with all 18 Big Ten schools. The pitch is simple: donate blood, log it, help your school win a $1 million prize, and maybe snag a limited-edition T-shirt while you're at it. Very college-sports-meets-public-service.
Why this matters
The timing is doing a lot of the heavy lifting here. The American Red Cross has declared a national blood crisis after donations sank to a four-year summer low, which means this isn't just a feel-good campus promo — it's tied to a real shortage that affects hospitals and patients nationwide.
Abbott says people can donate anywhere in the U.S. between Aug. 12 and Dec. 4, then log their donation when the competition officially kicks off on August 26. In other words: donate now, brag later.
The investor angle
This isn't likely to move the stock like a drug approval or earnings beat, but it does give Abbott another chance to flex its brand in public health. And in a world where companies spend millions trying to look useful, Abbott gets to be useful and visible at the same time.
Big picture: It's a PR-plus-purpose play that reinforces Abbott's healthcare identity while plugging into a genuinely urgent shortage. Not the kind of headline that changes a valuation model tomorrow — but the kind that quietly keeps a brand sticky.
